Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children

J Allergy Clin Immunol. 2007 Mar;119(3):747-50. doi: 10.1016/j.jaci.2006.10.045.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • CD4 Immunoadhesins / administration & dosage*
  • Child
  • Female
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Male
  • Recombinant Fusion Proteins / administration & dosage*
  • Recombinant Fusion Proteins / pharmacokinetics*

Substances

  • CD4 Immunoadhesins
  • CD4-IgG(2)
  • Recombinant Fusion Proteins

Grants and funding